CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Vitamin D +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00423358
NCT00423358N/ACompleted
CompareCT.gov

Treatment of Hypovitaminosis D in Rheumatoid Arthritis

University of Wisconsin, Madison·interventional·Posted Jan 18, 2007·Updated Aug 24, 2015

In Brief

A clinical study evaluating Vitamin D and placebo for Rheumatoid Arthritis and Hypovitaminosis D. Completed, enrolled 22 participants across 1 site.

Detailed Summary

This study recruits individuals with rheumatoid arthritis (RA) and low vitamin D concentrations. Subjects are dosed with vitamin D or placebo for one year. Primary outcome is change in bone turnover markers, additionally, bone mineral density and parameters of RA status are evaluated throughout the study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis, Hypovitaminosis D
CountriesUnited States
CollaboratorsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 18, 2007
Enrollment StartFeb 1, 2005
Primary CompletionAug 1, 2008
Study CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 19.5 years ago

Interventions

Vitamin Ddietary

Ergocalciferol 50,000 IU loading dose then twice monthly for one year

placebodietary

matching placebo